Shown to be 2x more effective than traditional silicone cream in clinical studies
Skinuva is a revolutionary scar cream providing fantastic results in minimal time. What makes it so effective? It is backed by science and uses highly selective growth factors which are shown to be twice as effective as silicone cream from our clinical trials. The 30 mL/1 fl. oz Skinuva™ Scar is ideal for smaller scars, less than 6 inches in size, including rhinoplasty scars, blepharoplasty scars, liposuction scars, laparoscopic surgery scars, and other small facial or body scars. It is recommended to apply Skinuva twice a day for a minimum of 3 – 6 months.
We heal scars better than them, and here's why.
Skinuva™ Scar was founded by Dr. Christopher Zoumalan, a Board-Certified Ophthalmic Plastic and Reconstructive Surgeon. Inspired by his passion for science and medicine, he dedicated the past several years researching wound-healing and identifying the best techniques to recover surgical scars in his patients that underwent surgery.
Unmet need in current topical scar therapy
Although there has been major medical advancements in surgical procedures to minimize scarring, patients are still faced with concerns of visible scars that remain post-surgery.
Since the introduction of silicone cream in the late 1990's there has been limited advancements in the topical scar therapy industry. Pertaining to the stagnate progress, Dr. Zoumalan and his team of scientists implemented medical literature and clinical data within their product development.
Patience in research and formulation were keys to success for Skinuva™ Scar
Selective ingredients such as specific Growth Factors were integrated within the formulation of Skinuva™ Scar to create what is now recognized as- one of the most advanced topical scar creams. Skinuva™ Scar is the first and only scar cream in the industry that uses selective Growth Factors in its formulation.
Scarless healing in fetuses: This knowledge was crucial in the development of Skinuva™ Scar
Scar free healing in fetuses occurs due to a complex upregulation and downregulation of certain growth factors. By utilizing such knowledge, Skinuva's team of scientists, clinicians, stem cell experts, and chemists formulated its first product in its Growth Factor Pipeline: Skinuva™ Scar.